Skip to main content
. 2016 Jun 11;64(4):1105–1120. doi: 10.1002/hep.28637

Figure 7.

Figure 7

Proposed therapeutic strategy. Schematic summarization of the proposed HCC therapeutic strategy, which shows that PLK1 inhibitor BI2536 induced mitosis defect and senescence, and the SMAC mimetic, LCL161, sensitized HCC cells to TNFα‐induced cell death. Combined treatment with these two drugs markedly repressed HCC.